Global X Genomics & Biotechnology ETF
GNOM
8 hedge funds and large institutions have $10.5M invested in Global X Genomics & Biotechnology ETF in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.72% less ownership
Funds ownership: 16.03% → 15.31% (-0.72%)
20% less capital invested
Capital invested by funds: $13M → $10.5M (-$2.55M)
20% less funds holding
Funds holding: 10 → 8 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$822K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$463 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$560K |
| 2 |
Jane Street
New York
|
-$477K |
| 3 |
AA
Advisory Alpha
Holland,
Michigan
|
-$14.5K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Citigroup
New York
| $9.5M | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $750K | +$822K | +14,202 | +1,663% |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $116K | +$463 | +8 | +0.3% |
|
4
Osaic Holdings
Scottsdale,
Arizona
| $51K | +$59.3K | +1,025 | New |
|
5
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $24K | – | – | – |
|
|
AA
6
Advisory Alpha
Holland,
Michigan
| $14K | -$14.5K | -250 | -51% |
|
|
BFEC
7
Benjamin F. Edwards & Company
St. Louis,
Missouri
| $10K | – | – | – |
|
|
APA
8
American Portfolios Advisors
Holbrook,
New York
| $7.79K | – | – | – |
|
|
9
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$560K | -8,965 | Closed |
|
|
10
Jane Street
New York
| – | -$477K | -7,645 | Closed |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| – | -$2K | -29 | Closed |
|
GNOM Hedge Fund Activity: Q1 2020 in Review
8 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q1 2020, worth a combined $10.5M — down 20% from $13M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of GNOM and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, adding an estimated $822K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $560K sold.
- 8 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q1 2020, down from 10 in Q4 2019.
- Funds reported $10.5M of Global X Genomics & Biotechnology ETF stock for Q1 2020, down 20% quarter-over-quarter.
- 1 fund opened new Global X Genomics & Biotechnology ETF positions in Q1 2020 and 3 closed out, a net change of -2 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q1 2020 was UBS Group, an estimated $822K added.
- The largest Global X Genomics & Biotechnology ETF seller in Q1 2020 was Susquehanna International Group, an estimated $560K sold.
Based on aggregated 13F filings for Q1 2020.